# Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis

> **NCT00662714** · PHASE3 · COMPLETED · sponsor: **Mukoviszidose Institut gGmbH** · enrollment: 73 (actual)

## Conditions studied

- Cystic Fibrosis
- Diabetes Mellitus

## Interventions

- **DRUG:** Repaglinide
- **DRUG:** short-acting Insulin (Actrapid)

## Key facts

- **NCT ID:** NCT00662714
- **Lead sponsor:** Mukoviszidose Institut gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2012-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662714, "Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00662714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*